Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureLucas Hoffman
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Cystic fibrosis pulmonary exacerbations
10.1016/j.jpeds.2005.10.019 · 2006
Exacerbations in cystic fibrosis: 1. Epidemiology and pathogenesis
10.1136/thx.2006.060889 · 2007
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation
10.1164/rccm.200909-1421oc · 2010
Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis
10.1002/ppul.21374 · 2011
Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa
10.1164/rccm.200309-1306oc · 2004
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
10.1016/j.jcf.2011.05.002 · 2011
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis
10.1136/thx.2010.137281 · 2011
Decade-long bacterial community dynamics in cystic fibrosis airways
10.1073/pnas.1120577109 · 2012
Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients
10.3109/00365548.2012.708942 · 2013
Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis
10.1164/rccm.200306-779oc · 2004
Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone
10.1164/ajrccm/141.4_pt_1.914 · 1990
Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures
10.1002/ppul.21221 · 2010
A framework for human microbiome research
10.1038/nature11209 · 2012
Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling
10.1128/jcm.41.8.3548-3558.2003 · 2003
Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
10.1073/pnas.0709804104 · 2007
Significance of the microbiome in obstructive lung disease
10.1136/thoraxjnl-2011-201183 · 2012
Topographical continuity of bacterial populations in the healthy human respiratory tract
10.1164/rccm.201104-0655oc · 2011
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
10.1136/thoraxjnl-2011-200932 · 2012
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
10.1371/journal.pone.0022702 · 2011
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations
10.1371/journal.pone.0045001 · 2012
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation
10.1513/annalsats.201211-107oc · 2013
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
10.1073/pnas.0804326105 · 2008
McKay agar enables routine quantification of the ‘Streptococcus milleri’ group in cystic fibrosis patients
10.1099/jmm.0.016592-0 · 2010
The genus Gemella: commensals or pathogens in cystic fibrosis?
2008
No additional external references are available.